<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="166315">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01681498</url>
  </required_header>
  <id_info>
    <org_study_id>12-010</org_study_id>
    <nct_id>NCT01681498</nct_id>
  </id_info>
  <brief_title>Fetal Electrocardiogram Extraction-Pilot Study</brief_title>
  <official_title>Fetal Electrocardiogram Extraction-Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Huntleigh Healthcare Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Huntleigh Healthcare Ltd</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a pilot study utilizing trans-abdominal ECG and Doppler Ultrasounds to assess the
      feasibility of extracting fECGs in a volunteer population.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Beat-to-beat fetal heart rate will be compared to the Doppler result.</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Beat-to-beat fetal heart rate will be compared to the Doppler result using Pearson Correlation.  Timing of PR, QT, and QS, if visible, will be compared with published normative values from the neonatology literature as these values are not otherwise obtainable in an ongoing pregnancy.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluate the presence of other fECG intervals.</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>The fECG Separation Algorithm used in this research incorporates the filtering of noise of very high level as compared with the signal to be retrieved , in combination with employment of SVD (Singular Value Decomposition) methods.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Pregnant Women</condition>
  <arm_group>
    <arm_group_label>Pregnant</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Prenatal care clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects must be pregnant women at least 18 years of age.

          -  Subject's fetus must be between the gestational ages of 16 weeks and term.

          -  Subjects must be able to tolerate 20 minutes (per fetus for which trans-abdominal ECG
             and Doppler ultrasounds will be performed) in the supine position.

          -  Subjects are willing to provide informed consent and are willing to participate in
             all procedures necessary to complete the study.

        Exclusion Criteria:

          -  Subjects must not have a physical or mental condition, in the opinion of the
             investigator, which will limit their ability to provide adequate consent.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Menachem H. Graupe, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wheaton Franciscan Healthcare</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Menachem H. Graupe, MD</last_name>
    <phone>414.259.7480</phone>
    <email>menachem.graupe@wfhc.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Maraty T. Gray, BS</last_name>
    <phone>414.447.3506</phone>
    <email>maraty.gray@wfhc.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Wheaton Franciscan, Inc. - St. Joseph</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Menachem H. Graupe, MD</last_name>
      <phone>414-259-7480</phone>
      <email>menachem.graupe@wfhc.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 23, 2013</lastchanged_date>
  <firstreceived_date>August 30, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pregnant</keyword>
  <keyword>fetal ecg</keyword>
  <keyword>ecg</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
